Skip to main content

Pediatric Long Term Follow Up ALTE05N1

Status: Open to Enrollment
Email us to enroll

Study details

View study details on www.clinicaltrials.gov.

Locations

  • Sacramento

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors to learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Sandra K Baril, M.D.
Sandra K Baril, M.D.
Principal investigator
View profile

Sub-Investigators

Saunders C Hsu, M.D., MPH, Janice K Ryu, M.D., Rachel Bito, M.D.

Email us to enroll

Related clinical trials

View all clinical trials
  • Clinical trial

    Pediatric B-Lymphoblastic Leukemia COG AALL1732

    A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLyLy

    Status: Open to Enrollment

  • Clinical trial

    Pediatric Cancer Project Every Child APEC14B1

    The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

    Status: Open to Enrollment

  • Clinical trial

    Adjuvant Astrocytomas Grade 3 A072301

    Phase III Trial of Radiotherapy Followed by Adjuvant Temozolomide in Combination With the IDH Inhibitor Vorasidenib vs Placebo in IDH-Mutated Newly-Diagnosed Grade 3 Astrocytomas

    Status: Open to Enrollment

  • Clinical trial

    Metastasis Brain NEO212-01

    An Open-label Phase 1/2 Dose Finding, Safety and Efficacy Study of Oral NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Uncontrolled Brain Metastasis in Patients With Select Solid Tumors

    Status: Open to Enrollment

  • Clinical trial

    Neoadjuvant Hodgkin Lymphoma COG AHOD2131

    A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?